×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

Amgen Announces Webcast of Second Quarter Financial Results

THOUSAND OAKS, Calif., Jul 7, 2004 (BUSINESS WIRE) -- In BW5140 issued July 7, 2004: First graph, first sentence of release should read: Amgen Inc. (Nasdaq:AMGN), the world's largest biotechnology company, today announced that it would report second quarter financial results on Thursday, July 22, 2004 after the financial markets close (sted first quarter financial results).

    The corrected release reads:

    AMGEN ANNOUNCES WEBCAST OF SECOND QUARTER FINANCIAL RESULTS

Amgen Inc. (Nasdaq:AMGN), the world's largest biotechnology company, today announced that it would report second quarter financial results on Thursday, July 22, 2004 after the financial markets close. The announcement will be followed by a conference call with the investment community at 2 p.m. PDT.

Participating in the call from Amgen will be Kevin Sharer, chairman, chief executive officer, and president, and other members of Amgen's senior management.

Live audio of the conference call will be simultaneously broadcast over the Internet and will be available to members of the news media, investors and the general public. The conference call is expected to last approximately one hour.

This event can be accessed by going to Amgen's Web site, www.amgen.com, and clicking on Investors. A link to the webcast is under the Events header. The event will be archived and available for replay for 72 hours after the event.

Amgen is a global biotechnology company that discovers, develops, manufactures and markets important human therapeutics based on advances in cellular and molecular biology.

SOURCE: Amgen Inc.

Amgen, Thousand Oaks
Sabrina Johnson, 805-447-4587 (media)
Laura Biswas, 805-447-1060 (investors)
Customize your Business Wire news & multimedia to match your needs.
Get breaking news from companies and organizations worldwide.
Logon for FREE today at www.BusinessWire.com.